GAR Live Life Sciences 2026 Conference – From deal to dispute: arbitration in life sciences M&A

Freshfields International Arbitration Partner Tom Walsh will be speaking on a panel titled, "From deal to dispute: arbitration in life sciences M&A" at the inaugural 2026 GAR Live: Life Sciences Conference on April 30, 2026 from 9:45-10:45 AM EDT.

Life sciences deals often involve complex earn-out structures, billion-dollar valuations, and cross-border considerations, making them fertile ground for disputes.

This panel brings together dealmakers, counsel, and arbitrators to explore how arbitration is shaping the resolution of M&A disputes in this sector. From drafting pitfalls to jurisdictional and procedural choices, to recurring substantive issues, panelists will examine what’s driving disputes and how parties can mitigate risk in high-stakes transactions.

Speakers:

• Preeti Bhagnani, Partner, White & Case
• James H. Carter, Independent Arbitrator, Carter Arbitration
• Donald LeGower, Senior Vice President - Litigation, Government Investigations, Employment and Policy Law, Bristol Myers Squibb
• Daniel Schimmel, Partner, Foley Hoag
• Thomas Walsh, Partner, Freshfields

For more information and registration, visit here.